CG Oncology, Inc. Common stock
CGON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,792,406 | $2,476,869 | $2,476,869 | $2,476,869 |
| - Cash | $257,068 | $8,266 | $88,143 | $53,607 |
| + Debt | $238 | $1,030 | $15,944 | $15,129 |
| Enterprise Value | $1,535,576 | $2,469,633 | $2,404,670 | $2,438,391 |
| Revenue | $1,139 | $204 | $191 | $10,358 |
| % Growth | 458.3% | 6.8% | -98.2% | – |
| Gross Profit | $1,139 | $204 | $176 | $10,348 |
| % Margin | 100% | 100% | 92.1% | 99.9% |
| EBITDA | -$114,634 | -$55,432 | -$35,231 | -$12,378 |
| % Margin | -10,064.4% | -27,172.5% | -18,445.5% | -119.5% |
| Net Income | -$88,039 | -$48,607 | -$35,443 | -$12,839 |
| % Margin | -7,729.5% | -23,827% | -18,556.5% | -124% |
| EPS Diluted | -1.41 | -1.02 | -0.66 | -0.28 |
| % Growth | -38.2% | -54.5% | -135.7% | – |
| Operating Cash Flow | -$78,713 | -$45,679 | -$29,804 | -$13,654 |
| Capital Expenditures | -$234 | $0 | -$14 | -$97 |
| Free Cash Flow | -$78,947 | -$45,679 | -$29,818 | -$13,751 |